NCT02883517
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital of Bordeaux - Hospital Saint André Bordeaux, France
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT02471911
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +14 more
- Locations
-
- Weill Cornell Medical College New York, United States
NCT01791595
- Conditions
- Adult Solid Tumor, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- Royal Marsden Hospital Sutton, London, United Kingdom
- The Beatson West of Scotland, Glasgow Glasgow, United Kingdom
- Leicester Royal Infirmary Leicester, United Kingdom
- University College London Hospitals London, United Kingdom
Completed
Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT05318391
- Conditions
- Gene Expression Profiling, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Yian Zhang Shanghai, Shanghai Municipality, China
Completed
Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
NCT03465527
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Kosin University Gospel Hospital Busan, Sue-gu, South Korea
NCT02499003
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Department of Hematology, Oncology and Pneumology; University Medical Center of the Johannes Gutenberg-University Mainz, RLP, Germany
NCT03364439
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- A.O. Niguarda Milan, MI, Italy
- Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, PZ, Italy
- A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, Italy
- A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy
Completed
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT02086604
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- Ohio State University, James Cancer Hospital Columbus, Ohio, United States
NCT02987400
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
- Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
- Kepler Universitätsklinikum Linz, Med Campus III.,Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria
- Universitätsklinik für Innere Med. III, PMU Salzburg Salzburg, Austria
NCT02077166
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Cedar Sinai Medical Center Los Angeles, California, United States
- UCLA Medical Center Los Angeles, California, United States